Lueck Lab
Welcome to the Lueck Lab
The Lueck lab focuses on the molecular genetics and experimental treatment of diseases resulting from nonsense mutations. They are investigating the use of engineered tRNAs for suppression of nonsense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) transcripts as therapeutic intervention for cystic fibrosis. Additionally, we am interested in the molecular genetics and experimental treatment of the trinucleotide repeat disorder myotonic dystrophy (DM1). Moving forward, we intend to study pre-mRNA splicing defects in DM1 to determine the causes of muscle weakness and wasting, and develop and test new therapeutic strategies to target the genetic misstep and reverse symptoms. More broadly, the lab is interested in applying membrane biophysics, molecular and cellular biology approaches to understand the molecular underpinning of genetic diseases and develop therapeutic interventions.
Attention Graduate Students, Undergraduate Students, Postdocs
We are looking for highly motivated individuals who are interested in conducting research in the area of RNA biology and their use as therapeutics and skeletal muscle ion channel biophysics. Please contact Professor Lueck and visit our working in the lab page for more details.
John D. Lueck, Ph.D.
Principal Investigator
Publications
View All Publications- Optimization of ACE-tRNAs function in translation for suppression of nonsense mutations.; Nucleic acids research. 2024 Nov 30.
- Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases.; bioRxiv : the preprint server for biology. 2024 Nov 14.
- Gz Enhanced Signal Transduction assaY (G Z ESTY) for GPCR deorphanization.; bioRxiv : the preprint server for biology. 2024 Jul 26.
- A cystic fibrosis gene editing approach that is on target.; Molecular therapy. Nucleic acids; Vol 35(2), pp. 102197. 2024 May 08.
News
Affiliations
- Pharmacology & Physiology
- Neurology
- Center for Musculoskeletal Research
- Center for RNA Biology: From Genome to Therapeutics
- Lung Biology and Disease Program
- NIH T32 Training Grant in Cellular, Biochemical & Molecular Sciences
- Pulmonary T32 Training Grant
- Biochemistry & Molecular Biology Ph.D. Program
- Cellular and Molecular Pharmacology and Physiology Ph.D. Program
- Master’s Degree in Pharmacology
- Master’s Degree in Physiology
- Medical Pharmacology Master's Degree
April 27, 2023
Pulling the Plug on Viral Infections: CRISPR isn’t Just About Cutting
March 16, 2022
Congratulations to Lily Cisco and Chrissi Heil on their Myotonic Dystrophy Foundation Fellowships!
September 19, 2021
The Lueck Lab is quoted in Chemical & Engineering News!
April 29, 2021
Hocking and Lueck Receive EDI Medicines Discovery Awards
Contact Us
Lueck Lab
601 Elmwood Ave
Rochester, NY 14642
(585) 273-2652